Sale!

CNGA3 Gene Achromatopsia Type 2 Genetic Test

3,600 د.إ

-36%

The “CNGA3 Gene Achromatopsia Type 2 Genetic Test” is a specialized diagnostic tool designed to detect mutations in the CNGA3 gene, which are responsible for Achromatopsia Type 2, a rare genetic disorder affecting vision. This condition is characterized by partial or total absence of color vision, light sensitivity, involuntary eye movements, and significantly reduced visual acuity. The test is crucial for accurate diagnosis, enabling personalized management and genetic counseling for affected individuals and their families. Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers reliable results, leveraging advanced genomic technologies. The cost for undergoing this genetic test is 3600 AED, reflecting the comprehensive analysis and expert interpretation that accompanies this service.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CNGA3 Gene Achromatopsia Type 2 Genetic Test

Welcome to DNA Labs UAE, where we offer the CNGA3 Gene Achromatopsia Type 2 Genetic Test at a cost of AED 3600.0. This test is designed to diagnose and provide genetic counseling for individuals with achromatopsia type 2, a rare genetic condition that affects color vision and causes vision impairment.

Test Components and Price

  • Test Name: CNGA3 Gene Achromatopsia Type 2 Genetic Test
  • Price: 3600.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ophthalmology Disorders
  • Doctor: Ophthalmologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CNGA3 Gene Achromatopsia Type 2 Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the CNGA3 Gene Achromatopsia Type 2 NGS Genetic DNA Test gene CNGA3.

Test Details

The CNGA3 gene is responsible for producing a protein called cyclic nucleotide-gated channel alpha-3. Mutations in this gene can lead to achromatopsia type 2, a condition that impairs color vision and overall visual acuity. The NGS genetic testing method allows us to sequence the entire CNGA3 gene or specific regions of it, enabling us to identify any changes or mutations in the DNA sequence.

By diagnosing achromatopsia type 2 through genetic testing, we can provide accurate information for genetic counseling and help affected individuals and their families better understand the condition. This knowledge can contribute to improved diagnosis, treatment, and management of achromatopsia type 2 and similar genetic conditions.

It is crucial to note that genetic testing should always be performed under the guidance of a healthcare professional. The results should be interpreted in the context of the patient’s medical history and symptoms.

Test Name CNGA3 Gene Achromatopsia type 2 Genetic Test
Components
Price 3600.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CNGA3 Gene Achromatopsia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CNGA3 Gene Achromatopsia type 2 NGS Genetic DNA Test gene CNGA3
Test Details

The CNGA3 gene is associated with a rare genetic condition known as achromatopsia type 2, which affects the ability to see colors and causes vision impairment. This condition is caused by mutations in the CNGA3 gene, which is responsible for producing a protein called cyclic nucleotide-gated channel alpha-3. This protein plays a crucial role in the function of cone cells in the retina, which are responsible for color vision and visual acuity.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the CNGA3 gene that may be responsible for achromatopsia type 2. This test involves sequencing the entire gene or specific regions of the gene to identify any changes or mutations in the DNA sequence. This information can then be used to diagnose the condition and provide genetic counseling to affected individuals and their families.

NGS genetic testing is a powerful tool for identifying genetic conditions like achromatopsia type 2 and can help to improve diagnosis, treatment, and management of these conditions. It is important to note that genetic testing should always be performed under the guidance of a healthcare professional and that results should be interpreted in the context of a patient’s medical history and symptoms.